News

26/03/2026

Psychedelics Advance as a New Therapeutic Pathway in Treatment-Resistant Depression

The therapeutic use of psychedelics continues to gain ground in psychiatry, particularly in the management of complex disorders such as treatment-resistant depression, where available options remain l...

20/03/2026

A Clinical Trial Investigates Whether Preventing Epilepsy Can Slow Alzheimer’s Disease in People With Down Syndrome

More than 90% of people with Down syndrome will develop symptoms of Alzheimer’s disease during their lifetime. And when epilepsy is added to that diagnosis, decline accelerates significantly. The LE...

19/03/2026

Cerebrovascular Lesions in Down Syndrome Do Not Follow a Linear Course

What has long been interpreted as permanent and irreversible vascular damage may not be exclusively so. In people with Down syndrome—one of the most robust populations for studying Alzheimer’s dis...

16/03/2026

International Grant Will Support a Project to Improve the Diagnosis of Tauopathies

Tauopathies, a group of neurodegenerative diseases that includes progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), remain one of the major diagnostic challenges in neurology to...

13/03/2026

Precision Nanoimmunotherapy Aims to Eliminate Stem Cells Responsible for Relapse in Acute Myeloid Leukemia

In acute myeloid leukemia, one of the main challenges is preventing relapse: although many patients respond to the initial treatment, leukemic stem cells capable of reactivating the disease may persis...